These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Identification of RC-33 as a potent and selective σ1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-scale synthesis, physicochemical characterization and in vitro metabolic stability. Rossi D; Marra A; Picconi P; Serra M; Catenacci L; Sorrenti M; Laurini E; Fermeglia M; Pricl S; Brambilla S; Almirante N; Peviani M; Curti D; Collina S Bioorg Med Chem; 2013 May; 21(9):2577-86. PubMed ID: 23498917 [TBL] [Abstract][Full Text] [Related]
23. Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine. Arbus C; Benyamina A; Llorca PM; Baylé F; Bromet N; Massiere F; Garay RP; Hameg A Eur J Pharm Sci; 2007 Dec; 32(4-5):357-66. PubMed ID: 17951033 [TBL] [Abstract][Full Text] [Related]
24. In vitro characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino]cyclohexanol [(+)-pIV] as a sigma-1 receptor ligand. Shiba K; Ogawa K; Mori H Bioorg Med Chem; 2005 Feb; 13(4):1095-9. PubMed ID: 15670917 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and pharmacological evaluation of Tic-hydantoin derivatives as selective sigma1 ligands. Part 1. Charton J; Cazenave Gassiot A; Girault-Mizzi S; Debreu-Fontaine MA; Melnyk P; Sergheraert C Bioorg Med Chem Lett; 2005 Nov; 15(21):4833-7. PubMed ID: 16140011 [TBL] [Abstract][Full Text] [Related]
26. Distinction between human cytochrome P450 (CYP) isoforms and identification of new phosphorylation sites by mass spectrometry. Redlich G; Zanger UM; Riedmaier S; Bache N; Giessing AB; Eisenacher M; Stephan C; Meyer HE; Jensen ON; Marcus K J Proteome Res; 2008 Nov; 7(11):4678-88. PubMed ID: 18828626 [TBL] [Abstract][Full Text] [Related]
34. An in vitro evaluation of the victim and perpetrator potential of the anticancer agent laromustine (VNP40101M), based on reaction phenotyping and inhibition and induction of cytochrome P450 enzymes. Nassar AE; King I; Paris BL; Haupt L; Ndikum-Moffor F; Campbell R; Usuki E; Skibbe J; Brobst D; Ogilvie BW; Parkinson A Drug Metab Dispos; 2009 Sep; 37(9):1922-30. PubMed ID: 19520774 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and binding affinities of methylvesamicol analogs for the acetylcholine transporter and sigma receptor. Shiba K; Ogawa K; Ishiwata K; Yajima K; Mori H Bioorg Med Chem; 2006 Apr; 14(8):2620-6. PubMed ID: 16434200 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and in vitro evaluation of tetrahydroisoquinolines with pendent aromatics as sigma-2 (σ2) selective ligands. Ashford ME; Nguyen VH; Greguric I; Pham TQ; Keller PA; Katsifis A Org Biomol Chem; 2014 Feb; 12(5):783-94. PubMed ID: 24306445 [TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of new bifunctional sigma-1 selective ligands with antioxidant activity. Prezzavento O; Arena E; Parenti C; Pasquinucci L; Aricò G; Scoto GM; Grancara S; Toninello A; Ronsisvalle S J Med Chem; 2013 Mar; 56(6):2447-55. PubMed ID: 23470245 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and pharmacological evaluation of benzannulated derivatives as potent and selective sigma-1 protein ligands. Donnier-Maréchal M; Carato P; Le Broc D; Furman C; Melnyk P Eur J Med Chem; 2015 Mar; 92():575-82. PubMed ID: 25602932 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]